Literature DB >> 85353

Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis.

F Naeim, J C Keesey, C Herrmann, J Lindstrom, E Zeller, R L Walford.   

Abstract

Twenty-eight patients with myasthenia gravis (MG), five with and 23 without thymoma, and 47 normal controls were typed for serologically defined HLA-A, B, C, and DRw antigens. Sera from all patients were titered for antibodies to acetylcholine receptors (AChR). The frequency of HLA-B8 and DRw3 in the non-thymoma MG patients was significantly higher than in the normal population. Most of the non-thymoma patients with AChR titers higher than the average level were positive for HLA-B8 and/or DRw3, while the majority of the HLA-B8(-) and/or DRw3(-) non-thymoma patients demonstrated AChR titers below average. These findings support the possibility of the existence of immune response genes in the HLA-B, DRw segment of the major histocompatibility complex which are concerned in the response to or recognition of autoantigens.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 85353     DOI: 10.1111/j.1399-0039.1978.tb01347.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  10 in total

1.  Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia.

Authors:  Claire Vandiedonck; Geneviève Beaurain; Matthieu Giraud; Catherine Hue-Beauvais; Bruno Eymard; Christine Tranchant; Philippe Gajdos; Jean Dausset; Henri-Jean Garchon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

2.  Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.

Authors:  A Melms; S Chrestel; B C Schalke; H Wekerle; A Mauron; M Ballivet; T Barkas
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

3.  Immune disease and HLA associations with myasthenia gravis.

Authors:  P O Behan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

4.  Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice.

Authors:  Huan Yang; Elzbieta Goluszko; Chella David; David K Okita; Bianca Conti-Fine; Teh-sheng Chan; Mathilde A Poussin; Premkumar Christadoss
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

5.  HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1.

Authors:  N M F van Gerven; Y S de Boer; A Zwiers; B J Verwer; J P H Drenth; B van Hoek; K J van Erpecum; U Beuers; H R van Buuren; J W den Ouden; R C Verdonk; G H Koek; J T Brouwer; M M J Guichelaar; J M Vrolijk; M J Coenraad; G Kraal; C J J Mulder; C M J van Nieuwkerk; E Bloemena; H W Verspaget; V Kumar; A Zhernakova; C Wijmenga; L Franke; G Bouma
Journal:  Genes Immun       Date:  2015-01-22       Impact factor: 2.676

6.  HLA-DQB1*05:02, *05:03, and *03:01 alleles as risk factors for myasthenia gravis in a Spanish cohort.

Authors:  Maria Salvado; Jose Luis Caro; Cecilia Garcia; Francesc Rudilla; Laura Zalba-Jadraque; Eva Lopez; Elia Sanjuan; Josep Gamez; Jose Manuel Vidal-Taboada
Journal:  Neurol Sci       Date:  2022-05-06       Impact factor: 3.830

7.  Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.

Authors:  W A Scherbaum; F Schumm; B Maisch; C Müller; A Fateh-Moghadam; S H Flüchter; F J Seif; G F Bottazzo; P A Berg
Journal:  Klin Wochenschr       Date:  1983-05-16

8.  Human leucocyte antigens A, B, C, and DRW in idiopathic "warm" autoimmune haemolytic anaemia.

Authors:  A Abdel-Khalik; L Paton; A G White; S J Urbaniak
Journal:  Br Med J       Date:  1980-03-15

9.  HLA antigens in Japanese patients with myasthenia gravis.

Authors:  K Matsuki; T Juji; K Tokunaga; M Takamizawa; H Maeda; M Soda; Y Nomura; M Segawa
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

10.  Familial myasthenia gravis.

Authors:  D Honeybourne; P A Dyer; P D Mohr
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.